12
Clinical Laboratory Testing: Providing Clinical Evidence for Diagnosis and Treatment Alan Mertz President American Clinical Laboratory Association

Clinical Laboratory Testing: Providing Clinical Evidence for Diagnosis and Treatment Alan Mertz President American Clinical Laboratory Association

Embed Size (px)

Citation preview

Page 1: Clinical Laboratory Testing: Providing Clinical Evidence for Diagnosis and Treatment Alan Mertz President American Clinical Laboratory Association

Clinical Laboratory Testing:Providing Clinical Evidence for

Diagnosis and TreatmentAlan Mertz

PresidentAmerican Clinical Laboratory Association

Page 2: Clinical Laboratory Testing: Providing Clinical Evidence for Diagnosis and Treatment Alan Mertz President American Clinical Laboratory Association

2

Most Medicare Beneficiaries Receive Lab Services from Hospitals or Independent Labs National Labs Make Up Only 20% of Total Medicare Spending

Data Sources: MedPAC, 2011 Data Book. G2 Intelligence, Lab Industry Strategic Outlook 2011 Market Trends and Analysis. ACLA internal analysis.

Medicare Spending on Clinical Lab Fee Schedule in 2010 ($8.1B Total)

LabCorp $0.73 Billion

9%

Quest Diagnostics Inc $0.90 Billion

11%

Hospitals $3.20 Billion

40%

Physician Office Labs $0.32 Billion

4%

Other Independent Labs $2.94 Billion

36%

Page 3: Clinical Laboratory Testing: Providing Clinical Evidence for Diagnosis and Treatment Alan Mertz President American Clinical Laboratory Association

Medicare Beneficiaries Living in Rural Areas are Primarily Served by Small Clinical Laboratories

Quest & LabCorp

21%

All Other Labs79%

Urban Counties: Laboratory Market Share in 2006

Quest & LabCorp

11%

All Other Labs89%

Rural Counties:Laboratory Market Share in 2006

Source: The National Market for Clinical Laboratory Testing, Medicare & Medicaid Research Review, 2012

Page 4: Clinical Laboratory Testing: Providing Clinical Evidence for Diagnosis and Treatment Alan Mertz President American Clinical Laboratory Association

Laboratory Test Reimbursement

• Most lab services are reimbursed under the Clinical Laboratory Fee Schedule (CLFS)– Small subset that require physician interpretation

reimbursed under Physician Fee Schedule• CLFS allows direct billing of labs for laboratory

services– Separates ordering clinician from entity getting paid

for the test• Protects beneficiaries and health care system from

incentive-driven overutilization of lab services

Page 5: Clinical Laboratory Testing: Providing Clinical Evidence for Diagnosis and Treatment Alan Mertz President American Clinical Laboratory Association

Clinical Lab Fee Schedule (CLFS) Created in 1984 with Annual Update for Inflation… But Payments Have Increased Only 7 Times in Past 30 Years

$-

$5.00

$10.00

$15.00

$20.00

$25.00

$10.00

$8.32

$21.81

Year

Medicare Payment for Lab Test ($10 in 1984)

Updated for Inflation

1984 2010

Page 6: Clinical Laboratory Testing: Providing Clinical Evidence for Diagnosis and Treatment Alan Mertz President American Clinical Laboratory Association

Congress Passed Cuts to CLFS in 2010, 2011 and 2012…

Current Law Calls for 8% Cut Over Next 5 Years*

* Includes impact of sequestration

-3% on1/1/2013-5% on 4/1/2013 -8% over

5 years

Productivity Adjustment (2010)

-1.75% Cut to Labs (2010)

-2% “Re-Basing” (2012)

Sequestration (2011)

Cuts to CLFS Payments

Page 7: Clinical Laboratory Testing: Providing Clinical Evidence for Diagnosis and Treatment Alan Mertz President American Clinical Laboratory Association

Projected Payments, Next 10 Years… With Inflation Updates

2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 $8.00

$8.50

$9.00

$9.50

$10.00

$10.50

$11.00

$11.50

$12.00

$12.50

$13.00

$10.00

$10.67

$12.87

Test Paid at $10 in 2010Updated Annually for Inflation

Page 8: Clinical Laboratory Testing: Providing Clinical Evidence for Diagnosis and Treatment Alan Mertz President American Clinical Laboratory Association

2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 $8.00

$8.50

$9.00

$9.50

$10.00

$10.50

$11.00

$11.50

$12.00

$12.50

$13.00

$10.00

$12.87

$9.88

2010 Baseline, pre-ACA

2013 Baseline, 2% Rebasing + Sequestration

Projected Payments for a Test Paid at $10 in 2010

Projected Payments, Next 10 Years… NO Inflation Updates

Page 9: Clinical Laboratory Testing: Providing Clinical Evidence for Diagnosis and Treatment Alan Mertz President American Clinical Laboratory Association

2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 $8.00

$8.50

$9.00

$9.50

$10.00

$10.50

$11.00

$11.50

$12.00

$12.50

$13.00

$10.00

$12.87

$9.88

$9.33

2010 Baseline, pre-ACA

2013 Baseline, 2% Rebasing + Sequestration

CBO Uniform Cost-Sharing, Restrict Medigap

Projected Payments for a Test Paid at $10 in 2010

Proposals for Combined Deductible & Uniform Coinsurance: Lab Test Payments Cut 20%

Page 10: Clinical Laboratory Testing: Providing Clinical Evidence for Diagnosis and Treatment Alan Mertz President American Clinical Laboratory Association

2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 $8.00

$8.50

$9.00

$9.50

$10.00

$10.50

$11.00

$11.50

$12.00

$12.50

$13.00

$10.00

$12.87

$9.88

$9.33

$8.98

2010 Baseline, pre-ACA2013 Baseline, 2% Rebasing + SequestrationCBO Uniform Cost-Sharing, Restrict Medigap20% Lab Coinsurance

Projected Payments for a Test Paid at $10 in 2010

20% Lab Coinsurance: Even Bigger Cuts, Since No Catastrophic Coverage

Page 11: Clinical Laboratory Testing: Providing Clinical Evidence for Diagnosis and Treatment Alan Mertz President American Clinical Laboratory Association

When Compared to Payments Adjusted for Inflation, Coinsurance Proposals Could Cut by Additional 20 – 30% Over Next 10 Years

2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 $8.00

$8.50

$9.00

$9.50

$10.00

$10.50

$11.00

$11.50

$12.00

$12.50

$13.00

$10.00

$10.67

$12.87

$9.88

$9.33

$8.98

2010 Baseline, pre-ACA

2013 Baseline, 2% Rebasing + Sequestration

CBO Uniform Cost-Sharing, Restrict Medigap

20% Lab Coinsurance

2013-12%

2015-20% to -24%

2022-27% to -30%Projected Payments for a Test Paid at $10 in 2010

Page 12: Clinical Laboratory Testing: Providing Clinical Evidence for Diagnosis and Treatment Alan Mertz President American Clinical Laboratory Association

Sources of Supplemental /Secondary Coverage for Medicare Beneficiaries

Employer, 13.9M, 35%

Medicare Advantage, 7.6M, 19%

Medigap, 7.2M, 18%

None, 4.4M, 11%

Other Public, 0.4M, 1%

Medicaid, 6.4M, 16%

Source: Examining Sources of Coverage Among Medicare Beneficiaries, Kaiser Family Foundation 2009